The molecular genetics and morphometry‐based endometrial intraepithelial neoplasia classification system predicts disease progression in endometrial hyperplasia …
JP Baak, GL Mutter, S Robboy… - … Journal of the …, 2005 - Wiley Online Library
BACKGROUND The objective of this study was to compare the accuracy of disease
progression prediction of the molecular genetics and morphometry‐based Endometrial …
progression prediction of the molecular genetics and morphometry‐based Endometrial …
Levonorgestrel‐impregnated intrauterine device as treatment for endometrial hyperplasia: a national multicentre randomised trial
A Ørbo, AB Vereide, M Arnes… - … Journal of Obstetrics …, 2014 - Wiley Online Library
Objective The purpose of this study was to investigate if the levonorgestrel‐impregnated
intrauterine device (LNG‐IUS, Mirena®) is safe and effective as therapy for low‐risk and …
intrauterine device (LNG‐IUS, Mirena®) is safe and effective as therapy for low‐risk and …
Treatment results of endometrial hyperplasia after prospective D-score classification: a follow-up study comparing effect of LNG-IUD and oral progestins versus …
A Ørbo, M Arnes, C Hancke, AB Vereide, I Pettersen… - Gynecologic …, 2008 - Elsevier
OBJECTIVES: Three different treatment options for endometrial hyperplasia were evaluated
in a prospective long-time follow-up study, comparing effects of intrauterine levonorgestrel …
in a prospective long-time follow-up study, comparing effects of intrauterine levonorgestrel …
Effect of levonorgestrel IUD and oral medroxyprogesterone acetate on glandular and stromal progesterone receptors (PRA and PRB), and estrogen receptors (ER-α …
AB Vereide, T Kaino, G Sager, M Arnes, A Ørbo - Gynecologic oncology, 2006 - Elsevier
OBJECTIVES:: The effect on progesterone and estrogen receptor expression in glands and
stroma after two different treatment regimens of endometrial hyperplasia was determined …
stroma after two different treatment regimens of endometrial hyperplasia was determined …
Prospective multicenter evaluation of the morphometric D-score for prediction of the outcome of endometrial hyperplasias
JPA Baak, A Ørbo, PJ Van Diest, M Jiwa… - The American journal …, 2001 - journals.lww.com
Prospective multicenter evaluation of the WHO classification and the morphometric D-score
to predict endometrial hyperplasia cancer progression. In 132 endometrial hyperplasias …
to predict endometrial hyperplasia cancer progression. In 132 endometrial hyperplasias …
Relapse risk of endometrial hyperplasia after treatment with the levonorgestrel‐impregnated intrauterine system or oral progestogens
A Ørbo, M Arnes, AB Vereide… - BJOG: An International …, 2016 - Wiley Online Library
Objective To investigate relapse rates after the successful treatment of patients with non‐
atypical endometrial hyperplasia who were randomised to either a levonorgestrel …
atypical endometrial hyperplasia who were randomised to either a levonorgestrel …
Computerised morphometrical analysis in endometrial hyperplasia for the prediction of cancer development. A long term retrospective study from northern Norway
A Ørbo, JPA Baak, I Kleivan, S Lysne… - Journal of Clinical …, 2000 - jcp.bmj.com
Aims—To evaluate and compare the long term prognostic value of the WHO classification
and the computerised multivariate morphometrical D score in endometrial hyperplasia. To …
and the computerised multivariate morphometrical D score in endometrial hyperplasia. To …
Bcl-2, BAX, and apoptosis in endometrial hyperplasia after high dose gestagen therapy: a comparison of responses in patients treated with intrauterine levonorgestrel …
AB Vereide, T Kaino, G Sager, A Ørbo - Gynecologic oncology, 2005 - Elsevier
OBJECTIVES.: The aim of the study was to investigate apoptosis as a growth regulatory
mechanism of gestagen in endometrial precancers and to compare differences in the …
mechanism of gestagen in endometrial precancers and to compare differences in the …
Significance of progesterone receptors (PR‐A and PR‐B) expression as predictors for relapse after successful therapy of endometrial hyperplasia: a retrospective …
ET Sletten, M Arnes, LM Lyså… - BJOG: An International …, 2019 - Wiley Online Library
Objective After successful progestin therapy for endometrial hyperplasia (EH), the risk of
relapse remains. We aimed to assess if immunohistochemical (IHC) expression of …
relapse remains. We aimed to assess if immunohistochemical (IHC) expression of …
Down-regulated progesterone receptor A and B coinciding with successful treatment of endometrial hyperplasia by the levonorgestrel impregnated intrauterine system
A Ørbo, M Arnes, I Pettersen, K Larsen… - Acta obstetricia et …, 2010 - Taylor & Francis
Objective. To investigate whether regression of endometrial hyperplasia observed after 3
months of treatment with levonorgestrel impregnated intrauterine system device (LNG-IUS) …
months of treatment with levonorgestrel impregnated intrauterine system device (LNG-IUS) …